Planet 13 Holdings (PLNH) Other Non-Current Liabilities (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Other Non-Current Liabilities came in at $1.3 million in Q1 2026, down 93.45% year-on-year from $19.3 million in Q1 2025, and down 96.17% on a QoQ basis from $33.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Other Non-Current Liabilities data on file, last reported at $1.3 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 93.45% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 93.45% decrease from a year earlier, with the FY2025 full-year figure at $33.0 million, up 71.01% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.3 million, down from $33.0 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for PLNH reached as high as $33.0 million in Q4 2025 and fell as low as $28000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $7.2 million across 5 years, with a median of $33000.0 in 2024.
- Across the five-year window, Other Non-Current Liabilities slumped 99.61% in 2022 and surged 81421.93% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $28000.0 in 2022, then changed by 0.0% to $28000.0 in 2023, then soared by 68905.27% to $19.3 million in 2024, then soared by 71.01% to $33.0 million in 2025, then slumped by 96.17% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.3 million in Q1 2026, $33.0 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 33.04 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 26.90 Mn |
| Mar 31, 2025 | 19.32 Mn |
| Dec 31, 2024 | 19.32 Mn |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 28,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Mar 31, 2021 | 7.21 Mn |